Key result
Multifaceted community pharmacist intervention fails to improve self-reported medication adherence at 6 months versus control.
Why the study?
Does a multifaceted community pharmacist intervention improve self-reported medication adherence and blood pressure in adults with primary hypertension?
RCT (n=395)
non-blinded
cluster-randomized
Does a multifaceted community pharmacist intervention improve self-reported medication adherence and blood pressure in adults with primary hypertension?
Absolute Event Rate: 73.5% vs 63.6%
p-value: p=0.23
A multifaceted pharmacist intervention did not significantly improve overall self-reported adherence but did significantly reduce systolic blood pressure and improved adherence in patients who were non-adherent at baseline.
Does not support pharmacist interventions to improve adherence in hypertension; challenges broad efficacy and leaves BP effects open for targeted trials.
WHAT IS KNOWN AND OBJECTIVES: About half of all patients taking antihypertensives discontinue treatment by 12 months. There is potential for substantial health gains at both individual and population levels through improved treatment adherence. The objective was to evaluate a community pharmacist intervention to improve adherence with antihypertensive medicines with a view to improving blood pressure (BP) control. DESIGN: prospective, non-blinded, cluster-randomized, controlled trial. PARTICIPANTS: adults with primary hypertension who obtained antihypertensives in the previous 6 months. Patients with poor refill adherence were preferentially identified with the help of a purpose-built software application. INTERVENTION: package comprising BP monitor; training on BP self-monitoring; motivational interviewing; medication use review; prescription refill reminders. FOLLOW-UP: six months. PRIMARY OUTCOME: change in proportion self-reporting medication adherence. Secondary outcome: BP changes. RESULTS: Participants (n = 395; intervention - 207; control - 188) had a mean age of 66.7 years; 51.1% were males. The proportion of adherent participants increased in both groups but was not significantly different between groups [57·2% to 63·6% (control) vs. 60·0% to 73·5% (intervention), P = 0·23]. The mean reduction in systolic BP was significantly greater in the intervention group (10·0 mmHg vs. 4·6 mmHg; P = 0·05). The proportion of patients who were non-adherent at baseline and adherent at 6 months was 22·6% (95%CI 5·1-40·0%) higher in the intervention group (61·8% vs. 39·2%, P = 0·007). Among participants with baseline BP above target, reduction of systolic BP was significantly greater in the intervention group [by 7·2 mmHg (95%CI 1·6-12·8 mmHg); (P = 0·01)]. Among participants non-adherent at baseline and above target BP, the proportion reporting adherence at 6 months was significantly greater in the intervention group [56·8% vs. 35·9%, P = 0·039). WHAT IS NEW AND CONCLUSION: This community pharmacist intervention resulted in improved adherence to antihypertensive medication and reduced systolic BP.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2014) conducted an RCT in primary hypertension (n=395). Multifaceted pharmacist intervention vs. Control was evaluated on change in proportion self-reporting medication adherence (p=0.23). A multifaceted community pharmacist intervention did not significantly increase self-reported medication adherence at 6 months compared to control (73.5% vs 63.6%, P=0.23).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: